交易 Corbus Pharmaceuticals Holdings, Inc. - CRBP CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
| 价差 | 0.212 | ||||||||
|
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
|
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | USD | ||||||||
| 保证金 | 5% | ||||||||
| 上市交易所 | United States of America | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
Corbus Pharmaceuticals Holdings Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
| 日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 36.454 | 0.370 | 1.03% | 36.084 | 37.594 | 35.034 |
| Apr 17, 2024 | 37.054 | -2.110 | -5.39% | 39.164 | 41.054 | 35.994 |
| Apr 16, 2024 | 41.094 | 0.270 | 0.66% | 40.824 | 44.784 | 39.964 |
| Apr 15, 2024 | 42.564 | 3.060 | 7.75% | 39.504 | 42.874 | 38.264 |
| Apr 12, 2024 | 40.754 | 3.470 | 9.31% | 37.284 | 40.754 | 37.284 |
| Apr 11, 2024 | 39.874 | 4.160 | 11.65% | 35.714 | 39.974 | 35.714 |
| Apr 10, 2024 | 37.824 | 2.170 | 6.09% | 35.654 | 38.154 | 35.244 |
| Apr 9, 2024 | 37.354 | -0.820 | -2.15% | 38.174 | 40.384 | 35.764 |
| Apr 8, 2024 | 39.814 | 0.980 | 2.52% | 38.834 | 41.654 | 36.114 |
| Apr 5, 2024 | 39.904 | 2.230 | 5.92% | 37.674 | 39.954 | 37.414 |
| Apr 4, 2024 | 38.474 | 1.440 | 3.89% | 37.034 | 40.534 | 37.034 |
| Apr 3, 2024 | 37.034 | 0.050 | 0.14% | 36.984 | 40.134 | 36.584 |
| Apr 2, 2024 | 37.084 | 0.590 | 1.62% | 36.494 | 40.004 | 34.834 |
| Apr 1, 2024 | 37.504 | 0.360 | 0.97% | 37.144 | 40.544 | 36.954 |
| Mar 28, 2024 | 38.364 | 4.720 | 14.03% | 33.644 | 39.724 | 33.634 |
| Mar 27, 2024 | 35.114 | 0.880 | 2.57% | 34.234 | 36.234 | 32.864 |
| Mar 26, 2024 | 35.554 | 1.970 | 5.87% | 33.584 | 38.034 | 33.584 |
| Mar 25, 2024 | 35.014 | 1.810 | 5.45% | 33.204 | 36.044 | 33.204 |
| Mar 22, 2024 | 34.374 | -2.610 | -7.06% | 36.984 | 37.784 | 34.374 |
| Mar 21, 2024 | 37.494 | -0.950 | -2.47% | 38.444 | 39.184 | 36.974 |
Corbus Pharmaceuticals Holdings, Inc. Events
| 时间（协调世界时） (UTC) | 国家 | 事件 |
|---|---|---|
| Tuesday, May 7, 2024 | ||
| 时间（协调世界时） (UTC) 12:30 | 国家 US
| 事件 Q1 2024 Corbus Pharmaceuticals Holdings Inc Earnings Release Q1 2024 Corbus Pharmaceuticals Holdings Inc Earnings ReleaseForecast（预报） -上一页 - |
| Thursday, May 16, 2024 | ||
| 时间（协调世界时） (UTC) 13:00 | 国家 US
| 事件 Corbus Pharmaceuticals Holdings Inc Annual Shareholders Meeting Corbus Pharmaceuticals Holdings Inc Annual Shareholders MeetingForecast（预报） -上一页 - |
| Friday, May 17, 2024 | ||
| 时间（协调世界时） (UTC) 12:00 | 国家 US
| 事件 Corbus Pharmaceuticals Holdings Inc Annual Shareholders Meeting Corbus Pharmaceuticals Holdings Inc Annual Shareholders MeetingForecast（预报） -上一页 - |
| Tuesday, August 6, 2024 | ||
| 时间（协调世界时） (UTC) 12:30 | 国家 US
| 事件 Q2 2024 Corbus Pharmaceuticals Holdings Inc Earnings Release Q2 2024 Corbus Pharmaceuticals Holdings Inc Earnings ReleaseForecast（预报） -上一页 - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 總收入 | 0 | 0.88171 | 3.93723 | 36.1436 | 4.82227 |
| 收入 | 0 | 0.88171 | 3.93723 | 36.1436 | 4.82227 |
| 總營業費用 | 39.8354 | 56.8707 | 126.747 | 113.248 | 61.57 |
| 銷售/一般/行政費用，總計 | 18.6986 | 20.4254 | 28.4802 | 23.6434 | 12.956 |
| 研究與開發 | 16.1368 | 36.4453 | 98.2672 | 89.6048 | 48.614 |
| 營業收入 | -39.8354 | -55.989 | -122.81 | -77.1046 | -56.7477 |
| 利息收入（費用），非經營淨值 | -2.46268 | -1.5514 | -1.72936 | 1.06902 | 1.07557 |
| 稅前淨收入 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 稅後淨收入 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 未計算非常項目前的淨收益 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 淨收入 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 普通股股東可獲收益 (不含非經常性項目) | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 普通股股東可獲收益 (含非經常性項目) | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 攤薄淨收入 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 攤薄後加權平均股 | 4.17068 | 4.09967 | 2.60444 | 2.12976 | 1.8998 |
| 扣除特別項目的每股攤薄盈利 | -10.1535 | -11.1327 | -42.7229 | -33.5501 | -29.3042 |
| 每股正常攤薄盈利 | -8.95464 | -10.9849 | -42.7229 | -33.5501 | -29.3042 |
| 非常規項目總計 | |||||
| 其他，淨值 | -0.04877 | 11.9 | 13.2702 | 4.58184 | |
| 異常費用（收入） | 5 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| 總收入 | 0 | 0 | 0 | 0 | 0 |
| 收入 | 0 | 0 | 0 | 0 | 0 |
| 總營業費用 | 8.18899 | 17.297 | 10.7968 | 8.18146 | 12.34 |
| 銷售/一般/行政費用，總計 | 3.94029 | 3.90868 | 4.55406 | 4.07327 | 4.84037 |
| 研究與開發 | 4.24871 | 13.3883 | 6.24276 | 4.10819 | 2.49964 |
| 營業收入 | -8.18899 | -17.297 | -10.7968 | -8.18146 | -12.34 |
| 利息收入（費用），非經營淨值 | -0.77751 | -0.67729 | -0.35778 | -0.67798 | -0.7002 |
| 其他，淨值 | 0.18266 | 0.22951 | 0.27555 | 0.07771 | -0.20868 |
| 稅前淨收入 | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 稅後淨收入 | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 未計算非常項目前的淨收益 | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 淨收入 | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 普通股股東可獲收益 (不含非經常性項目) | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 普通股股東可獲收益 (含非經常性項目) | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 攤薄淨收入 | -8.78384 | -17.7448 | -10.8791 | -8.78172 | -13.2489 |
| 攤薄後加權平均股 | 4.2777 | 4.18156 | 4.15711 | 4.17561 | 4.1752 |
| 扣除特別項目的每股攤薄盈利 | -2.0534 | -4.24359 | -2.61698 | -2.1031 | -3.17324 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| 每股正常攤薄盈利 | -2.0534 | -4.24359 | -2.61698 | -2.1031 | -1.97569 |
| 異常費用（收入） | 0 | 0 | 0 | 5 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 流動資産總額 | 60.1811 | 100.205 | 92.0746 | 38.1547 | 44.2403 |
| 現金和短期投資 | 59.197 | 97.6471 | 85.4334 | 31.7487 | 41.7485 |
| 现金 | 3.80516 | 6.75159 | 1.82578 | 0.88412 | 0.80894 |
| 現金等價物 | 13.1976 | 18.255 | 83.6077 | 30.8646 | 40.9395 |
| 應收賬款總額，淨額 | 0 | 2.57833 | 2.68107 | ||
| 預付的費用 | 0.79162 | 2.36501 | 3.71286 | 3.72493 | 2.49184 |
| 其他流動資産，總計 | 0.19248 | 0.19248 | 0.35 | 0 | |
| 總資産 | 66.3119 | 107.73 | 102.295 | 49.1425 | 46.9893 |
| 物業/廠房/設備，總計 - 淨額 | 5.49807 | 7.00181 | 9.31636 | 10.9029 | 2.70521 |
| 物業/廠房/設備，總計 - 總額 | 8.59129 | 9.37405 | 11.6652 | 12.3088 | 3.37179 |
| 累計折舊，總計 | -3.09322 | -2.37224 | -2.34884 | -1.40596 | -0.66658 |
| 其他長期資産，總計 | 0.63277 | 0.52381 | 0.90394 | 0.08497 | 0.04382 |
| 流動負債總額 | 12.6399 | 17.0075 | 31.8978 | 34.8877 | 18.0893 |
| 應付賬款 | 2.17396 | 1.78228 | 7.38118 | 11.0914 | 6.34534 |
| 預提費用 | 7.28012 | 11.2303 | 23.0095 | 23.0437 | 9.85119 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 長期債務的當前部分/資本租賃 | 3.14899 | 3.86128 | 0.71016 | 0.75266 | 0.39431 |
| 其他流動負債，總計 | 0.03687 | 0.13371 | 0.797 | 0 | 1.4985 |
| 負債總額 | 33.3219 | 38.6222 | 57.02 | 42.9849 | 19.4652 |
| 長期債務總額 | 15.9844 | 15.6363 | 18.029 | 0 | 0 |
| 其他負債，總計 | 4.69756 | 5.97842 | 7.09317 | 8.09723 | 1.37589 |
| 總權益 | 32.99 | 69.108 | 45.2749 | 6.15757 | 27.5241 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| 普通股 | 0.00042 | 0.01252 | 0.00989 | 0.00647 | 0.00573 |
| 額外實收資本 | 425.196 | 418.892 | 349.358 | 198.975 | 148.889 |
| 留存收益（累計赤字） | -392.081 | -349.734 | -304.093 | -192.824 | -121.37 |
| 總負債和股東權益 | 66.3119 | 107.73 | 102.295 | 49.1425 | 46.9893 |
| 已發行普通股總數 | 4.1713 | 4.17395 | 3.29476 | 2.15555 | 1.90806 |
| 應收賬款 - 貿易，淨額 | 0 | 1.6183 | 2.68107 | ||
| 長期債務 | 15.9844 | 15.6363 | 18.029 | ||
| 短期投資 | 42.1943 | 72.6405 | |||
| 其他權益，總計 | -0.12609 | -0.06245 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| 流動資産總額 | 31.206 | 38.274 | 45.865 | 60.1811 | 67.3478 |
| 現金和短期投資 | 28.7332 | 36.5659 | 44.227 | 59.197 | 66.2292 |
| 现金 | 1.99596 | 1.72889 | 2.89716 | 3.80516 | 3.80611 |
| 現金等價物 | 9.25284 | 6.62046 | 4.42728 | 13.1976 | 8.63754 |
| 短期投資 | 17.4844 | 28.2166 | 36.9026 | 42.1943 | 53.7856 |
| 應收賬款總額，淨額 | |||||
| 應收賬款 - 貿易，淨額 | |||||
| 預付的費用 | 2.28026 | 1.51562 | 1.44552 | 0.79162 | 0.92616 |
| 其他流動資産，總計 | 0.19248 | 0.19248 | 0.19248 | 0.19248 | 0.19248 |
| 總資産 | 36.2834 | 43.7234 | 51.6453 | 66.3119 | 73.8306 |
| 物業/廠房/設備，總計 - 淨額 | 4.39874 | 4.76002 | 5.12041 | 5.49807 | 5.87229 |
| 物業/廠房/設備，總計 - 總額 | 7.80649 | 8.01496 | 8.39551 | 8.59129 | 8.78111 |
| 累計折舊，總計 | -3.40775 | -3.25494 | -3.27509 | -3.09322 | -2.90883 |
| 其他長期資産，總計 | 0.6787 | 0.68937 | 0.65986 | 0.63277 | 0.61048 |
| 流動負債總額 | 31.5423 | 16.3859 | 14.3589 | 12.6399 | 17.4692 |
| 應付賬款 | 4.71353 | 1.50573 | 1.32299 | 2.17396 | 1.37422 |
| 預提費用 | 8.94237 | 7.77604 | 7.78697 | 7.28012 | 6.07764 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 長期債務的當前部分/資本租賃 | 17.8496 | 7.06725 | 5.21212 | 3.14899 | 9.88364 |
| 其他流動負債，總計 | 0.03687 | 0.03687 | 0.03687 | 0.03687 | 0.13371 |
| 負債總額 | 35.9724 | 34.2028 | 35.1863 | 33.3219 | 31.8845 |
| 長期債務總額 | 0.775 | 13.8194 | 13.9724 | 15.9844 | 9.38585 |
| 長期債務 | 0.775 | 13.8194 | 13.9724 | 15.9844 | 9.38585 |
| 其他負債，總計 | 3.65506 | 3.99753 | 6.85501 | 4.69756 | 5.02944 |
| 總權益 | 0.31102 | 9.52059 | 16.459 | 32.99 | 41.9461 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
| 普通股 | 0.00044 | 0.00044 | 0.00042 | 0.00042 | 0.01253 |
| 額外實收資本 | 428.981 | 428.153 | 426.352 | 425.196 | 423.342 |
| 留存收益（累計赤字） | -428.663 | -418.609 | -409.825 | -392.081 | -381.202 |
| 其他權益，總計 | -0.00804 | -0.02379 | -0.06847 | -0.12609 | -0.20687 |
| 總負債和股東權益 | 36.2834 | 43.7234 | 51.6453 | 66.3119 | 73.8306 |
| 已發行普通股總數 | 4.42368 | 4.42368 | 4.21513 | 4.1713 | 4.17561 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
| 经营活动产生的现金 | -37.5444 | -48.1837 | -99.6857 | -45.7207 | -30.0673 |
| 经营活动产生的现金 | 0.763 | 0.99982 | 1.12385 | 0.73938 | 0.49394 |
| 非现金物品 | 8.06298 | 12.1534 | 13.6647 | 12.5179 | 8.10229 |
| 已付现金利息 | 1.96958 | 1.74088 | 0.62915 | 0.02945 | 0.01044 |
| 营运资金的变化 | -4.02351 | -15.6965 | -3.20492 | 12.4757 | 17.0086 |
| 投资活动产生的现金 | 30.0741 | -73.4165 | -0.48449 | -2.74254 | -2.30042 |
| 资本支出 | -0.01345 | -0.05417 | -0.48449 | -2.74254 | -2.30042 |
| 融资活动产生的现金 | -0.53362 | 60.8234 | 154.875 | 38.4635 | 11.4197 |
| 融资现金流项目 | 0 | -1.82044 | -6.03942 | -2.57155 | -0.69018 |
| 股票的发行（报废），净额 | 0 | 62.5861 | 142.201 | 40.6771 | 12.0527 |
| 债务的发行（退还），净额 | -0.53362 | 0.05778 | 18.7135 | 0.35798 | 0.05719 |
| 现金净变化 | -8.00392 | -60.7768 | 54.7047 | -9.99978 | -20.948 |
| 其他投资现金流量项目，总计 | 30.0876 | -73.3624 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -17.7448 | -42.3469 | -31.4678 | -22.6861 | -9.43724 |
| Cash From Operating Activities | -15.115 | -37.5444 | -30.0895 | -22.8444 | -10.6153 |
| Cash From Operating Activities | 0.18187 | 0.763 | 0.5786 | 0.3878 | 0.19572 |
| Non-Cash Items | 1.22002 | 8.06298 | 6.78652 | 5.24585 | 2.75334 |
| Cash Interest Paid | 0.64146 | 1.96958 | 1.40721 | 0.88743 | 0.431 |
| Changes in Working Capital | 1.22795 | -4.02351 | -5.98672 | -5.79193 | -4.12716 |
| Cash From Investing Activities | 5.5497 | 30.0741 | 18.2944 | 24.2657 | 42.9622 |
| Capital Expenditures | 0 | -0.01345 | -0.01345 | -0.01345 | -0.01345 |
| Other Investing Cash Flow Items, Total | 5.5497 | 30.0876 | 18.3078 | 24.2791 | 42.9756 |
| Cash From Financing Activities | -0.11301 | -0.53362 | -0.76794 | -0.65723 | -0.32713 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
| Issuance (Retirement) of Stock, Net | 0.03706 | 0 | 0 | 0 | 0 |
| Issuance (Retirement) of Debt, Net | -0.15007 | -0.53362 | -0.76794 | -0.65723 | -0.32713 |
| Net Change in Cash | -9.67828 | -8.00392 | -12.563 | 0.76403 | 32.0197 |
差價合約交易計算器
如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模（槓桿 x 投資）：
打開
關閉
做空 做多
Corbus Pharmaceuticals Company profile
关于 Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings, Inc.专注于开发适用于从免疫肿瘤学到纤维化等疾病状态的免疫调节剂。 公司的管线包括阻断TGFβ激活的抗整合素单克隆抗体和激活或抑制内皮素系统的小分子。 公司的管线包括抗整合素单克隆抗体（mAbs），1型大麻素受体（CB1）和Lenabasum。 mAbs是用于治疗癌症和纤维化，抑制转化生长因子β（TGFβ）的激活。 它的CRB-601是一种抗αvβ8的毫安培，正在开发为与现有疗法（包括检查点抑制剂）相结合的实体瘤的潜在治疗方法。 大麻受体1型（CB1）是一种反向激动剂，旨在治疗肥胖症和相关代谢疾病。 Lenabasum是一种新型的、合成的、口服的分子，可以选择性地激活大麻素受体2型（CB2）。
| Industry: | Bio Therapeutic Drugs |
500 River Ridge Drive
NORWOOD
MASSACHUSETTS 02062
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗？
加入成为全球610,000万多名交易者的一份子，选择利用Capital.com进行交易吧。